Ondine Biomedical Inc. Notification of Major Holdings
26 November 2024 - 4:00AM
RNS Regulatory News
RNS Number : 5680N
Ondine Biomedical Inc.
25 November 2024
TR-1:
Standard form for notification of major holdings
2.
Reason for Notification
This was caused by an IPO.
3.
Details of person subject to the notification
obligation
City
of registered office (if applicable)
Country of registered office (if applicable)
4.
Details of the shareholder
Full
name of shareholder(s) if different from the person(s) subject to
the notification obligation, above
City
of registered office (if applicable)
Country of registered office (if applicable)
5.
Date on which the threshold was crossed or
reached
6.
Date on which Issuer notified
7.
Total positions of person(s) subject to the notification
obligation
|
|
% of
voting rights attached to shares (total of 8.A)
|
% of
voting rights through financial instruments (total of 8.B 1 + 8.B
2)
|
Total of both in % (8.A + 8.B)
|
Total number of voting rights held in issuer
|
|
Resulting situation on the date on
which threshold was crossed or reached
|
10.299591
|
0.000000
|
10.299591
|
40588235
|
|
Position of previous notification
(if applicable)
|
N/A
|
N/A
|
N/A
|
|
8.
Notified details of the resulting situation on the date on which
the threshold was crossed or reached
8A.
Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible)
|
Number of direct voting rights (DTR5.1)
|
Number of indirect voting rights (DTR5.2.1)
|
% of
direct voting rights (DTR5.1)
|
% of
indirect voting rights (DTR5.2.1)
|
|
CA68234M2058
|
|
40588235
|
|
10.299591
|
|
Sub Total 8.A
|
40588235
|
10.299591%
|
8B1.
Financial Instruments according to (DTR5.3.1R.(1)
(a))
|
Type
of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Number of voting rights that may be acquired if the instrument
is exercised/converted
|
% of
voting rights
|
|
|
|
|
|
|
|
Sub Total 8.B1
|
|
|
|
8B2.
Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
|
Type
of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Physical or cash settlement
|
Number of voting rights
|
% of
voting rights
|
|
|
|
|
|
|
|
|
Sub Total 8.B2
|
|
|
|
9.
Information in relation to the person subject to the notification
obligation
2. Full chain of controlled
undertakings through which the voting rights and/or the financial
instruments are effectively held starting with the ultimate
controlling natural person or legal entities (please add additional
rows as necessary)
|
Ultimate controlling person
|
Name
of controlled undertaking
|
% of
voting rights if it equals or is higher than the notifiable
threshold
|
% of
voting rights through financial instruments if it equals or is
higher than the notifiable threshold
|
Total of both if it equals or is higher than the notifiable
threshold
|
|
M&G Plc
|
M&G Plc (Parent
company)
|
10.299591%
|
|
10.299591%
|
|
M&G Plc
|
M&G Group Regulated Entity
Holding Company Limited (wholly owned subsidiary of M&G
Plc)
|
10.299591%
|
|
10.299591%
|
|
M&G Plc
|
M&G Group Limited (wholly owned
subsidiary of M&G Group Regulated Entity Holding Company
Limited)
|
10.299591%
|
|
10.299591%
|
|
M&G Plc
|
M&G FA Limited (wholly owned
subsidiary of M&G Group Limited)
|
10.299591%
|
|
10.299591%
|
|
M&G Plc
|
M&G Investment Management
Limited (wholly owned subsidiary of M&G FA Limited)
|
10.299591%
|
|
10.299591%
|
10.
In case of proxy voting
The
number and % of voting rights held
The
date until which the voting rights will be held
11.
Additional Information
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
HOLFZMZMVKLGDZM
Ondine Biomedical (LSE:OBI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Ondine Biomedical (LSE:OBI)
Historical Stock Chart
From Dec 2023 to Dec 2024
